NM_005629.4(SLC6A8):c.130G>T (p.Gly44Cys) AND Developmental disorder
- Germline classification:
- Uncertain significance (1 submission)
- Last evaluated:
- Feb 17, 2021
- Review status:
- Somatic classification
of clinical impact: - None
- Review status:
- Somatic classification
of oncogenicity: - None
- Review status:
- Record status:
- current
- Accession:
- RCV001843769.1
Allele description [Variation Report for NM_005629.4(SLC6A8):c.130G>T (p.Gly44Cys)]
NM_005629.4(SLC6A8):c.130G>T (p.Gly44Cys)
Condition(s)
- Name:
- Developmental disorder
- Identifiers:
- MedGen: C0008073
-
RecName: Full=Pyrokinin-6; AltName: Full=FXPRL-amide
RecName: Full=Pyrokinin-6; AltName: Full=FXPRL-amidegi|59798106|sp|P84365.1|PPK6_DERKEProtein
-
nuclear pore complex protein Nup205 [Rattus norvegicus]
nuclear pore complex protein Nup205 [Rattus norvegicus]gi|157820537|ref|NP_001102090.1|Protein
-
Genome-wide chromatin profiles of PBRM1 Drug treatment [RNA-Seq]
Genome-wide chromatin profiles of PBRM1 Drug treatment [RNA-Seq]Genome-wide chromatin profiles of PBRM1 Drug treatment [RNA-Seq]BioProject
-
PREDICTED: Mus musculus prominin 1 (Prom1), transcript variant X19, mRNA
PREDICTED: Mus musculus prominin 1 (Prom1), transcript variant X19, mRNAgi|1907161198|ref|XM_006503789.3|Nucleotide
-
Adprhl1 ADP-ribosylhydrolase like 1 [Mus musculus]
Adprhl1 ADP-ribosylhydrolase like 1 [Mus musculus]Gene ID:234072Gene
Your browsing activity is empty.
Activity recording is turned off.
See more...Assertion and evidence details
Last Updated: Dec 24, 2023